NVentures
Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Europe, Asia, Singapore, China, India, Brazil, France, Mexico, South Korea, South Africa, Israel, Chile, Argentina, Colombia, Peru, Ecuador
Industries Focus
- Technology
- Healthcare
- Energy
- Automotive
- EdTech
- FinTech
- Artificial Intelligence
- Gaming
- Biotech
- Agtech
- Semiconductors
- Data Centers
- Robotics
- Quantum Computing
- Cloud Computing
- Biotechnology
- Consumer Electronics
- Enterprise Software
- Clean Technology
- Autonomous Vehicles
- Data Center
- Additive Manufacturing
Investment Size:
1,000,000 to 20,000,000 USD
Investor Details Founded: 2022
NVentures is NVIDIA's corporate venture capital arm, established to invest in technology companies that are strategically relevant to NVIDIA's business. The firm focuses on startups that utilize NVIDIA's platforms across various industries, aiming to generate strong financial returns and enhance the company's ecosystem. NVentures has made investments in sectors such as healthcare, manufacturing, and autonomous systems, supporting companies that leverage NVIDIA's technologies to drive innovation and growth.
The investment strategy of NVentures is centered on identifying and partnering with visionary entrepreneurs who are solving complex problems and reshaping industries. By providing capital, technical expertise, and access to NVIDIA's resources, NVentures seeks to accelerate the development and adoption of cutting-edge technologies. The firm typically invests in seed to Series B funding rounds, with initial investments ranging from approximately $1 million for promising seed-stage companies to around $20 million for more mature Series A or B opportunities.
NVentures' portfolio includes a diverse array of companies, such as Genesis Therapeutics, Inceptive, Terray, Charm, Evozyne, Generate, and Superluminal, all of which are revolutionizing drug discovery. Other notable investments include QuEra, a leader in neutral-atom quantum computing, and Commonwealth Fusion Systems, a startup focused on nuclear fusion energy. By strategically investing in these companies, NVentures aims to foster innovation that aligns with NVIDIA's mission to advance computing technologies and address global challenges.
Requirements
- Alignment with NVIDIA's strategic interests
- Innovative technology solutions
- Scalable business models
- Experienced management teams
- Potential for significant market impact
- Strong management teams
Contact
[Official Website Hidden]
[HQ Location Hidden]
Portfolio Companies
- Quantinuum
- QuEra
- PsiQuantum
- Moon Surgical
- Outrider
- nTop
- Charm Therapeutics
- Relation Therapeutics
- Neocis
- Inceptive
- Abridge
- Bedrock Robotics
- Carbon Robotics
- FieldAI
- Flywheel
- Freeform
- Generalist AI
- Generate Biomedicines
- Genesis Therapeutics
- Luma Labs
- Terray
- Charm
- Evozyne
- Generate
- Superluminal
- Commonwealth Fusion Systems
Mentioned In
-
$24.95
-
$24.95
-
$24.95
-
$19.95
-
$9.95
-
$14.95
-
$19.95
-
$29.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of NVentures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim